Witkowski G, Lode H, Höffken G, Koeppe P
Eur J Clin Microbiol. 1982 Aug;1(4):233-7. doi: 10.1007/BF02019714.
Pharmacokinetic parameters after oral administration of 500 mg amoxicillin, 125 mg potassium clavulanate and 625 mg of their combination (augmentin) were determined in a randomized crossover study in ten healthy volunteers. The absolute bioavailability of amoxicillin (AUCoral/AUCi.v.) was 0.70 +/- 0.12. The mean maximum serum concentration of amoxicillin was 6.5 +/- 1.6 mg/l after administration alone and 6.5 +/- 1.4 mg/l after administration in combination. The respective values for potassium clavulanate were 3.4 +/- 1.4 mg/l and 2.8 +/- 1.1 mg/l. With both substances there was no significant difference between the pharmacokinetic parameters after administration alone and in combination. The AUC for amoxicillin was 19.5 +/- 5.4 h x mg/l after administration alone and 23.2 +/- 10.6 h x mg/l after administration in combination. The respective value for potassium clavulanate were 7.8 +/- 3.2 h x mg/l and 7.3 +/- 2.0 h x mg/l.
在一项针对10名健康志愿者的随机交叉研究中,测定了口服500毫克阿莫西林、125毫克克拉维酸钾以及625毫克二者组合(阿莫西林克拉维酸钾)后的药代动力学参数。阿莫西林的绝对生物利用度(AUCoral/AUCi.v.)为0.70±0.12。单独给药后阿莫西林的平均最大血清浓度为6.5±1.6毫克/升,联合给药后为6.5±1.4毫克/升。克拉维酸钾的相应值分别为3.4±1.4毫克/升和2.8±1.1毫克/升。两种药物单独给药和联合给药后的药代动力学参数均无显著差异。阿莫西林单独给药后的AUC为19.5±5.4小时×毫克/升,联合给药后为23.2±10.6小时×毫克/升。克拉维酸钾的相应值分别为7.8±3.2小时×毫克/升和7.3±2.0小时×毫克/升。